Free Trial

Ceredex Value Advisors LLC Sells 12,287 Shares of Xylem Inc. (NYSE:XYL)

Xylem logo with Industrial Products background

Ceredex Value Advisors LLC cut its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 7.2% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 159,167 shares of the industrial products company's stock after selling 12,287 shares during the period. Ceredex Value Advisors LLC owned about 0.07% of Xylem worth $21,492,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Norden Group LLC purchased a new stake in shares of Xylem during the first quarter worth $2,821,000. First Trust Direct Indexing L.P. grew its stake in shares of Xylem by 6.3% in the 1st quarter. First Trust Direct Indexing L.P. now owns 7,912 shares of the industrial products company's stock valued at $1,023,000 after buying an additional 469 shares in the last quarter. BNP Paribas Financial Markets increased its holdings in Xylem by 21.5% in the first quarter. BNP Paribas Financial Markets now owns 379,273 shares of the industrial products company's stock worth $49,017,000 after buying an additional 66,997 shares during the last quarter. Connecticut Wealth Management LLC raised its position in Xylem by 6.0% during the first quarter. Connecticut Wealth Management LLC now owns 1,945 shares of the industrial products company's stock valued at $251,000 after acquiring an additional 110 shares in the last quarter. Finally, Resonant Capital Advisors LLC bought a new position in Xylem during the first quarter valued at approximately $201,000. Institutional investors and hedge funds own 87.96% of the company's stock.

Xylem Price Performance

Shares of XYL stock traded down $2.32 during mid-day trading on Friday, reaching $119.46. The company's stock had a trading volume of 1,925,015 shares, compared to its average volume of 981,687. The firm's 50-day moving average is $132.78 and its two-hundred day moving average is $135.13. The company has a market cap of $29.02 billion, a P/E ratio of 34.93, a PEG ratio of 2.14 and a beta of 1.05. Xylem Inc. has a 1-year low of $93.86 and a 1-year high of $146.08. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.96.

Xylem (NYSE:XYL - Get Free Report) last posted its earnings results on Thursday, October 31st. The industrial products company reported $1.11 EPS for the quarter, hitting the consensus estimate of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The business had revenue of $2.10 billion during the quarter, compared to the consensus estimate of $2.17 billion. During the same quarter last year, the company earned $0.99 EPS. Xylem's revenue was up .2% on a year-over-year basis. On average, research analysts predict that Xylem Inc. will post 4.26 earnings per share for the current year.

Xylem Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 26th. Investors of record on Thursday, August 29th were given a dividend of $0.36 per share. The ex-dividend date was Thursday, August 29th. This represents a $1.44 dividend on an annualized basis and a yield of 1.21%. Xylem's dividend payout ratio (DPR) is presently 42.11%.

Analyst Upgrades and Downgrades

XYL has been the topic of several analyst reports. TD Cowen restated a "hold" rating and set a $138.00 price target on shares of Xylem in a research note on Tuesday, September 3rd. Royal Bank of Canada cut their target price on Xylem from $163.00 to $162.00 and set an "outperform" rating on the stock in a report on Friday. Robert W. Baird decreased their price target on Xylem from $175.00 to $154.00 and set an "outperform" rating for the company in a research note on Friday. Stifel Nicolaus boosted their target price on Xylem from $170.00 to $172.00 and gave the stock a "buy" rating in a report on Wednesday, July 31st. Finally, UBS Group started coverage on shares of Xylem in a report on Tuesday, August 13th. They set a "buy" rating and a $165.00 price target for the company. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $148.25.

Check Out Our Latest Stock Analysis on XYL

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

→ Banking failure dead ahead (From Porter & Company) (Ad)

Should you invest $1,000 in Xylem right now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ISRG Stock Surges: AI and Healthcare Innovation at the Core
Energy Vault’s 100% Stock Jump: CEO Discusses $350M Project in Australia in MarketBeat CEO Series
Market Shifts After Election: What Stocks Could Benefit Most?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines